awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28082910-A30AC0D2-BEF7-49BD-A5F5-3EB4D24C35A8
Q28082910-A30AC0D2-BEF7-49BD-A5F5-3EB4D24C35A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082910-A30AC0D2-BEF7-49BD-A5F5-3EB4D24C35A8
Trial Watch: Proteasomal inhibitors for anticancer therapy
P2860
Q28082910-A30AC0D2-BEF7-49BD-A5F5-3EB4D24C35A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082910-A30AC0D2-BEF7-49BD-A5F5-3EB4D24C35A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8686d274f70c35e55f90f930a4d6747f2a7ea863
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).